种族多样男性前列腺癌主动监测的前瞻性观察研究
本研究基于前瞻性主动监测(AS)数据库,评估非洲裔美国男性(AA)在低危前列腺癌AS中的风险升级情况。共纳入158名至少接受2次前列腺穿刺的男性(66%为AA),中位随访2.7年。结果显示AA与非AA男性在组织学升级或转为治疗方面无显著差异,无患者发生转移或死于前列腺癌。
要点
- AA男性低危前列腺癌可安全采用与非AA男性相同的AS方案。
- 中位随访2.7年,AA与非AA在升级或治疗进展上无显著差异。
- 研究期间无患者出现转移或前列腺癌特异性死亡。
核心结论
- AA男性低危前列腺癌可安全地遵循与非AA男性相同的AS方案进行随访。
研究设计与样本
- 前瞻性观察性研究,查询东南路易斯安那退伍军人事务医疗中心前瞻性AS数据库。
- 纳入158名低危或极低危前列腺癌男性(Gleason 3+3,PSA<10,≤cT2a),至少接受2次前列腺穿刺(含诊断和确认穿刺),其中AA 104人(66%)。
主要发现
- 中位随访2.7年,AS方案3年时57% AA和61%白人无升级或治疗证据。
- 种族间在升级或进展至治疗方面无显著差异。
- 7例(4%)死于非前列腺癌原因,无患者出现转移或死于前列腺癌。
临床怎么用
- AA男性低危前列腺癌可选择AS并采用与非AA男性相同的随访方案。
局限性
- 随访时间较短(中位2.7年),需更长期随访分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the risk upgrading of active surveillance (AS), we reviewed the outcomes of African American men (AA) after electing AS. AS is the standard of care for men with low-grade prostate cancer (PCa). AA are known to have more advanced PCa features and are more likely to die from PCa, thus subsequent disease progression for AA on AS is unclear. METHODS: A prospectively maintained AS database from the Southeast Louisiana Veterans Administration Medical Center, New Orleans, Lousiana was queried. We identified men with low- and very low-risk PCa (Gleason 3 + 3, PSA <10, ≤CT2a) who had undergone at least 2 prostate biopsies, including initial diagnostic and subsequent confirmatory prostate biopsies. Descriptive and comparative statistical analysis was performed using R version 3.5.1. RESULTS: From a total of 274 men on AS (70% AA), 158 men met inclusion criteria (104 AA [66%]). All patients underwent at least 2 biopsies, and 29% underwent 3 or more biopsies. The median follow-up was 2.7 years. At 3 years on AS protocol, 57% AA and 61% Caucasians demonstrated no evidence of upgrading or treatment. No significant difference was observed between upgrading or progression to treatment when comparing racial groups. Seven (4%) patients in this cohort died from non PCa-specific causes, but no patients demonstrated metastasis or death from PCa over the course of study. CONCLUSION: AA men with low-risk PCa can be safely followed with the same AS protocol as non-AA men. Further analysis with longer follow up is ongoing.
引用
- Greenberg JW, Leinwand G, Feibus AH, et al. Prospective Observational Study of a Racially Diverse Group of Men on Active Surveillance for Prostate Cancer. Urology. 2020. PMID: 33166542. doi:10.1016/j.urology.2020.09.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。